[The IMPACT study-PSA-based prostate screening in Lynch syndrome]
- PMID: 35403897
- DOI: 10.1007/s00120-022-01809-4
[The IMPACT study-PSA-based prostate screening in Lynch syndrome]
References
Literatur
-
- Page EC, Bancroft EK, Brook MN et al (2019) Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers. Eur Urol 76(6):831–842 - DOI
-
- Raymond VM, Mukherjee B, Wang F et al (2013) Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol 31(14):1713–1718. https://doi.org/10.1200/JCO.2012.44.1238 - DOI - PubMed - PMC
-
- Eldred-Evans D, Burak P, Connor MJ et al (2021) Population-based prostate cancer screening with magnetic resonance imaging or ultrasonography: the IP1-PROSTAGRAM study. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2020.7456 - DOI - PubMed - PMC
-
- Segal N, Margel D (2020) Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening. Ann Oncol 31(11):1545–1552 - DOI
-
- Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2021) S3-Leitlinie Prostatakarzinom, Langversion 6.0, AWMF Registernummer: 043/022OL. http://www.leitlinienprogramm-onkologie.de/leitlinien/prostatakarzinom/ . Zugegriffen: 12. Febr. 2022
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous